Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study ...
Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
The 2026 Shaffer Research Grants were awarded to Kun-Che Chang, PhD, Shruthi Karnam, PhD, Kate Keller, PhD, Naoki Kiyota, MD, PhD, Gillian McLellan, PhD, Kiyoharu Miyagishima, PhD, Kerstin Nundel, PhD ...
Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...
A 1:1 randomized clinical trial compared personalized coaching plus electronic adherence monitoring against standard mailed ...
Certain diet and lifestyle measures, such as being physically active, may have beneficial effects on glaucoma, including improving blood flow to the eyes and lowering eye pressure. Herbal supplements ...
Glaucoma can silently damage your optic nerve, leading to irreversible vision loss. Learn the early signs, risk factors, and ...
Explore the silent thief of sight: glaucoma. This article sheds light on the urgent need for awareness and action to prevent ...
Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the ...
Health experts in Plateau and Kaduna States have raised an alarm over the growing burden of glaucoma, urging Nigerians to undergo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results